Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enantioselective Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent CN108602808A enables high-purity nebivolol intermediate production. Discover cost reduction in pharma manufacturing and scalable supply solutions.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Advanced enantioselective process for oxadiazine intermediates. Reduces waste and improves chirality for agrochemical manufacturing. Reliable supply chain partner.
Patent CN115803318A details an enantioselective route for high-purity tetrahydroquinoline intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103857656B details enantioselective pyrrolidine synthesis offering cost reduction in agrochemical intermediate manufacturing and high-purity supply chain advantages.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.